IKTInhibikase Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Inhibikase Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IKTThis | $322M#8 | — | 2.1x#5 | — | -100.0%#5 | -75.4%#9 | — | -31.5%#5 | — | — | 48.1%#5 | — |
| GRML | $477M#1 | — | 8.2x#8 | — | — | -71.6%#8 | — | -18.2%#4 | -14.6%#2 | — | -89.7%#10 | — |
| XFOR | $349M#2 | 2.5x#2 | 2.2x#6 | 10.0x#3 | 1273.2%#2 | -111.5%#10 | -247.4%#3 | -50.9%#8 | -582.0%#3 | — | 9.1%#6 | — |
| OCGN | $344M#3 | — | — | 78.0x#4 | 8.8%#4 | -25.9%#6 | -1425.7%#4 | — | — | — | -12.9%#7 | — |
| LXEO | $342M#4 | — | 1.5x#2 | 523.1x#5 | — | -1.7%#4 | -16706.0%#5 | -42.5%#7 | — | — | -19.9%#8 | — |
| IPSC | $340M#5 | — | 1.5x#3 | 3.1x#2 | 1556.8%#1 | 92.4%#3 | -15.8%#1 | -4.1%#2 | -9.3%#1 | — | 286.4%#1 | — |
| CMPX | $330M#6 | — | 2.0x#4 | — | -100.0%#5 | -34.7%#7 | — | -40.0%#6 | — | — | -49.2%#9 | — |
| AGEN | $325M#7 | 2.4x#1 | — | 2.8x#1 | 10.4%#3 | 98.7%#2 | -17.7%#2 | — | — | — | 61.5%#3 | — |
| SABS | $308M#9 | 14.1x#4 | 1.4x#1 | — | -100.0%#5 | 138.9%#1 | — | 6.2%#1 | — | — | 61.2%#4 | — |
| PALI | $293M#10 | 2.6x#3 | 2.4x#7 | — | — | -16.2%#5 | — | -13.8%#3 | — | — | 179.4%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice